secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kymera Therapeutics, Inc. (KYMR)
CIK:        0001815442
Form:       8-K
Filed at:   2022-08-19T23:59:59+00:00
Accession:  0001193125-22-224656
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kymera raises $150M PIPE with 2.77M shares at $26 and 3M pre-funded warrants
----------------------------------------------------------------------------

- Private placement of 2,769,228 common shares at $26.00 and 3,000,000 pre-funded warrants at $25.9999.
- Gross proceeds of ~$150M expected; closing on August 22, 2022 subject to customary conditions.
- Proceeds to fund working capital, R&D, and general corporate purposes.
- Post-closing cash, equivalents, and investments expected to exceed $600M as of August 31, 2022.
- Offering led by a US healthcare fund and BVF; includes Avoro, EcoR1, Redmile, Rock Springs, T. Rowe Price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815442/000119312522224656/0001193125-22-224656-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815442/000119312522224656/d247240d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-224656

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer